ASU’s Autism/Aspergers Research Program, directed by Fulton Schools Professor James Adams, is partnering with a research foundation to do the first clinical trial of a new therapy developed by Adams and his research team to treat some of the ailments associated with autism. The trial will focus on the potential for the Microbiota Transfer Therapy to combat the effects of Pitt-Hopkins syndrome, a rare genetic disorder often classified on the autism spectrum. The hope is for the treatment to alleviate or reduce constipation and other gastrointestinal and gut problems that often plague children with Pitt-Hopkins syndrome.